EVOSEP and ReSyn Biosciences partner to integrate their technologies into new clinical proteomics solutions
The ability to process large and clinically relevant cohorts in a robust and high-throughput manner is important to unlocking the full potential of proteomics for precision medicine.
Source: news-medical.net